US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

The FDA previously agreed that together, these studies could constitute two adequate and well-controlled trials to support a potential New Drug Application ... injections due to the high treatment ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Obesity and diabetes are strongly correlated—and, given the optical problems that can occur due to what the American Academy of Ophthalmology calls “diabetic eye disease,” heeding vision changes can ...

Table of Contents Our top picks for January Everything new on Apple TV+ in January Last month’s top picks Apple TV+ is the rare streaming service that almost exclusively produces original ...

After a virtual workout in the Movement Studio, gear up for some infrared therapy, a new treatment to ease stiffness, soreness and inflammation, as well as reduce pain and improve muscle repair.

No time? No problem! Here are 8 lunchtime beauty treatments and wellness hacks for a stress-free festive season to boost your holiday spirit Lunchtime glow-ups: 8 quick beauty treatments and ...

HealthDay News — Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl ... The researchers found that during a ...